Back to Search Start Over

Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

Authors :
Cristina Bouzas
Rosario Pastor
Silvia Garcia
Margalida Monserrat-Mesquida
Miguel Ángel Martínez-González
Jordi Salas-Salvadó
Dolores Corella
Albert Goday
J. Alfredo Martínez
Ángel M. Alonso-Gómez
Olga Fernández-Barceló
Jesús Vioque
Dora Romaguera
José Lopez-Miranda
Ramón Estruch
Francisco J. Tinahones
José Lapetra
Lluís Serra-Majem
Blanca Riquelme-Gallego
Vicente Martín-Sánchez
Xavier Pintó
Miguel Delgado-Rodriguez
Pilar Matía
Josep Vidal
Jersy-Jair Cardenas-Salas
Lidia Daimiel
Emilio Ros
Estefanía Toledo
Josep M. Manzanares
Inmaculada Gonzalez-Monge
Miguel-Ángel Muñoz
Diego Martinez-Urbistondo
Lucas Tojal-Sierra
Carlos Muñoz-Bravo
Salvador Miralles-Gisbert
Marian Martin
Antonio García-Ríos
Sara Castro-Barquero
José Carlos Fernández-García
José Manuel Santos-Lozano
F. Javier Basterra-Gortari
Liliana Gutiérrez-Carrasquilla
Patricia Guillem-Saiz
Alba Satorres
Itziar Abete
Carolina Sorto-Sanchez
Javier Díez-Espino
Nancy Babio
Montse Fitó
Josep A. Tur
Source :
Biomedicine & Pharmacotherapy. 161:114561
Publication Year :
2023
Publisher :
Elsevier BV, 2023.

Abstract

Funding sponsor Funding number Acronym Balearic Islands Health Research Institute<br />EU-COST 35/2011, CA16112<br />Fondo de Investigación para la Salud<br />IDISBA CB12/03, CIBEROBN CB06/03<br />Margalida Comas DG R+D+I<br />Ministry of Science, Spain<br />European Commission 201630.10, EAT2BENICE_H2020_SFS2016<br />European Research Council 2013–2018, 340918<br />Generalitat Valenciana PROMETEO/2017/017<br />Instituto de Salud Carlos III<br />Funding sponsor Funding number Acronym Balearic Islands Health Research Institute EU-COST 35/2011, CA16112 Fondo de Investigación para la Salud IDISBA CB12/03, CIBEROBN CB06/03 Margalida Comas DG R+D+I Ministry of Science, Spain European Commission See opportunities by EC See opportunities (opens in new window) 201630.10, EAT2BENICE_H2020_SFS2016 EC European Research Council See opportunities by ERC See opportunities (opens in new window) 2013–2018, 340918 ERC Generalitat Valenciana See opportunities by GVA See opportunities (opens in new window) PROMETEO/2017/017 GVA Instituto de Salud Carlos III 2013ACUP00194, PI13/00233, PI13/00272, PI13/00462, PI13/00492, PI13/00673, PI13/00728, PI13/01056, PI13/01090, PI13/01123, PI13/02184, PI14/00618, PI14/00636, PI14/00696, PI14/00728, PI14/00853, PI14/00972, PI14/01206, PI14/01374, PI14/01471, PI14/01722, PI14/01919, PI16/00366, PI16/00381, PI16/00473, PI16/00501, PI16/00533, PI16/00662, PI16/01094, PI16/01120, PI16/01522, PI16/01873, PI17/00215, PI17/00508, PI17/00525, PI17/00532, PI17/00764, PI17/00855, PI17/00926, PI17/01183, PI17/01347, PI17/01441, PI17/01732, PI17/01827, PI19/00017, PI19/00309, PI19/00386, PI19/00576, PI19/00781, PI19/00957, PI19/01032, PI19/01226, PI19/01332, PI19/01560, PI20/00138, PI20/00339, PI20/00456, PI20/00557, PI20/00886, PI20/01158, PI20/01532, PI20/01802<br />Consejería de Salud y Familias, Junta de Andalucía PI0137/2018, PI0458/2013, PS0358/2016

Details

ISSN :
07533322
Volume :
161
Database :
OpenAIRE
Journal :
Biomedicine & Pharmacotherapy
Accession number :
edsair.doi.dedup.....cd538543bac92915fc43953173a8c922
Full Text :
https://doi.org/10.1016/j.biopha.2023.114561